Hologic, Inc. (HOLX) DCF Valuation

Valoración de DCF de Hologic, Inc. (HOLX)

US | Healthcare | Medical - Instruments & Supplies | NASDAQ
Hologic, Inc. (HOLX) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Hologic, Inc. (HOLX) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Diseñada para la precisión, nuestra calculadora DCF Hologic, Inc. (HOLX) le permite evaluar la valoración de Hologic utilizando datos financieros del mundo real al tiempo que proporciona flexibilidad completa para modificar todos los parámetros esenciales para mejorar las proyecciones.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020		 AY2
2021		 AY3
2022		 AY4
2023		 AY5
2024		 FY1
2025		 FY2
2026		 FY3
2027		 FY4
2028		 FY5
2029
Revenue 3,776.4 5,632.3 4,862.8 4,030.4 4,030.3 4,215.3 4,408.8 4,611.2 4,822.9 5,044.3
Revenue Growth, % 0 49.14 -13.66 -17.12 -0.00248114 4.59 4.59 4.59 4.59 4.59
EBITDA 1,496.7 2,861.6 2,113.4 1,110.6 1,296.2 1,632.3 1,707.2 1,785.6 1,867.6 1,953.3
EBITDA, % 39.63 50.81 43.46 27.56 32.16 38.72 38.72 38.72 38.72 38.72
Depreciation 376.0 406.9 430.1 323.4 309.0 351.7 367.8 384.7 402.4 420.9
Depreciation, % 9.96 7.22 8.84 8.02 7.67 8.34 8.34 8.34 8.34 8.34
EBIT 1,120.7 2,454.7 1,683.3 787.2 987.2 1,280.6 1,339.4 1,400.9 1,465.2 1,532.5
EBIT, % 29.68 43.58 34.62 19.53 24.49 30.38 30.38 30.38 30.38 30.38
Total Cash 701.0 1,170.3 2,339.5 2,722.5 2,333.6 1,794.9 1,877.3 1,963.5 2,053.6 2,147.9
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 1,028.9 942.7 617.6 625.6 600.4
Account Receivables, % 27.25 16.74 12.7 15.52 14.9
Inventories 395.1 501.2 623.7 617.6 679.8 542.7 567.7 593.7 621.0 649.5
Inventories, % 10.46 8.9 12.83 15.32 16.87 12.88 12.88 12.88 12.88 12.88
Accounts Payable 178.8 215.9 197.7 175.2 203.8 185.8 194.3 203.2 212.6 222.3
Accounts Payable, % 4.73 3.83 4.07 4.35 5.06 4.41 4.41 4.41 4.41 4.41
Capital Expenditure -156.4 -162.7 -127.2 -150.2 -140.2 -142.1 -148.6 -155.4 -162.5 -170.0
Capital Expenditure, % -4.14 -2.89 -2.62 -3.73 -3.48 -3.37 -3.37 -3.37 -3.37 -3.37
Tax Rate, % 8.74 8.74 8.74 8.74 8.74 8.74 8.74 8.74 8.74 8.74
EBITAT 1,247.4 1,945.7 1,380.0 530.9 900.9 1,075.6 1,125.0 1,176.6 1,230.6 1,287.1
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF 221.8 2,207.1 1,867.3 679.7 1,061.3 1,270.3 1,294.1 1,353.5 1,415.7 1,480.7
WACC, % 8.5 8.37 8.39 8.3 8.45 8.4 8.4 8.4 8.4 8.4
PV UFCF
SUM PV UFCF 5,349.9
Long Term Growth Rate, % 3.00
Free cash flow (T + 1) 1,525
Terminal Value 28,224
Present Terminal Value 18,854
Enterprise Value 24,204
Net Debt 498
Equity Value 23,706
Diluted Shares Outstanding, MM 238
Equity Value Per Share 99.79

What You Will Get

  • Real HOLX Financials: Access to historical and projected data for precise valuation.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
  • Dynamic Calculations: Intrinsic value and NPV are computed automatically.
  • Scenario Analysis: Explore various scenarios to assess Hologic’s future performance.
  • User-Friendly Design: Designed for professionals but easy to navigate for beginners.

Key Features

  • Comprehensive Financial Data: Hologic, Inc.'s (HOLX) historical financial statements and pre-filled projections.
  • Customizable Parameters: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Valuation: Observe Hologic, Inc.'s (HOLX) intrinsic value update instantly.
  • Intuitive Visualizations: Dashboard graphs illustrate valuation outcomes and essential metrics.
  • Designed for Precision: A professional-grade tool tailored for analysts, investors, and finance professionals.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Hologic, Inc. (HOLX) data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Hologic, Inc. (HOLX)’s intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for Hologic, Inc. (HOLX)?

  • Accurate Data: Up-to-date Hologic financials provide dependable valuation outcomes.
  • Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to fit your forecasts.
  • Time-Saving: Built-in calculations save you the effort of starting from the ground up.
  • Professional-Grade Tool: Tailored for investors, analysts, and consultants in the healthcare sector.
  • User-Friendly: Simple design and clear instructions make it accessible for all users.

Who Should Use Hologic, Inc. (HOLX)?

  • Healthcare Investors: Make informed investment choices with a comprehensive analysis of Hologic's market performance.
  • Medical Analysts: Streamline your research with a detailed financial model tailored for Hologic, Inc. (HOLX).
  • Consultants: Efficiently modify the provided data for client discussions or strategic presentations regarding Hologic's offerings.
  • Health Sector Enthusiasts: Enhance your knowledge of the medical technology industry through in-depth case studies of Hologic, Inc. (HOLX).
  • Educators and Students: Leverage it as a valuable resource in courses focused on healthcare finance and investment strategies.

What the Template Contains

  • Historical Data: Includes Hologic, Inc.'s (HOLX) past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Hologic, Inc.'s (HOLX) intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Hologic, Inc.'s (HOLX) financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.